A phase I study to evaluate the effect and recommended dose of 5-FU(rapid infusion and drip infusion)/l-LV therapy for advanced and/or recurrent colon cancer (OGSG 0406)
Phase 1
- Conditions
- advanced/recurrent colorectal cancer
- Registration Number
- JPRN-UMIN000000766
- Lead Sponsor
- OGSG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1.with severe bone marrow suppression 2.with a severe infection 3.with severe cardiac disease 4.with some other severe diseases 5.under a poor general condition 6.under diarrhea which continues more than three days 7.with double cancers which were treated within recent 5 years except carcinoma in situ. 8.with familial polyposis or hereditary disease 9.under pregnancy or nursing 10.with a history of allergic response to Levoholinate or fluorouracil 11.re-registration to this study 12.doctors' decision not to register
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method